medigraphic.com
ISSN 1561-3011 (Electronic)

2012, Number 1

<< Back Next >>

Rev Cubana Invest Bioméd 2012; 31 (1)

Identification and antimicrobial sensitivity of gramnegative bacteria causing pneumonia in HIV/AIDS patients

García CT, Martínez MI, Salazar RD, Pérez MM, Pérez ÁJ

Language: Spanish
References: 35
Page: 53-62
PDF size: 194.62 Kb.


ABSTRACT

Gramnegative bacteria are considered to be a common cause of pneumonia in HIV/AIDS patients. The emergence of a large number of resistant microorganisms has made it necessary to use antibiograms to decide what treatment will be applied to these patients.
Objectives: identify gramnegative bacteria causing pneumonia in HIV/AIDS patients and determine the antimicrobial sensitivity of the microorganisms isolated.
Methods: a prospective descriptive study of 85 patients with HIV/AIDS and presumed diagnosis of bacterial pneumonia was carried out at "Pedro Kouri" Institute applying clinical and radiological criteria. Sputum and blood samples were collected to be cultured. The bacteria isolated and their antimicrobial sensitivity were determined using the mini-Api (bioMérieux) semiautomated system.
Results: seventy-four potentially pathogenic bacteria were isolated, of which 32 (43.2 %) were classified as gramnegative. The prevailing ones were Klebsiella pneumoniae (11 strains: 34.3 %), Pseudomonas spp. (8 strains: 25 %) and Escherichia coli (4 strains: 12,5 %). Escherichia coli exhibited the highest resistance percentage. 75 % of the strains were sensitive to amikacin. No resistance was found to meropenem, and more than 50% of the enterobacteria identified, with the exception of E. coli, were sensitive to third-generation cephalosporins, ciprofloxacin, amikacin and cotrimoxazol. Pseudomonas spp. showed resistance to cotrimoxazol (87 %) and ticarcillin (75 %).
Conclusions: gramnegative bacteria cause pneumonia in HIV/AIDS patients to a considerable extent. There continue to be strains which are resistant to various antimicrobial drugs. However, cephalosporins, quinolones and carbapenemics exhibit adequate activity against these bacteria.


REFERENCES

  1. Madeddu G, Porqueddu E, Cambosu F, Saba F, Fois A. Bacterial community acquired pneumonia in HIV-infected inpatients in the highly active antiretroviral therapy era. Infection. 2008 May;10:167-9.

  2. CDC. Revised classification system for HIV infection and expanded surveillance case definition for AIDS among adolescents and adults. Morbidity and Mortality Weekly Report. 1993;41:1-17.

  3. Caiaffa WT, Graham NM, Vlahov D. Bacterial pneumonia in adult populations with human immunodeficiency virus (HIV) infection. Am J Epidemiol. 1993;138:909-22.

  4. Biedenbach D, Moet G, Jones J. Occurrence and antimicrobial resistance pattern comparisons among bloodstream infection isolates from SENTRY Antimicrobial Surveillance Program. Diagn Microbiol Infect Dis. 2004;50:59-69.

  5. Cabrera L, Palma S, Garcés M. Aislamientos bacterianos más frecuentes de muestras biológicas de pacientes infectados con el virus de la inmunodeficiencia humana (VIH). Rev Cubana Med Trop. 2003;55(2):112-4.

  6. Dropulic LK, Leslie JM, Eldred LJ. Clinical manifestations and risk factors of Pseudomonas aeruginosa infection in patients with AIDS. J Infect Dis.1995;171:930-7.

  7. Organización Mundial de la Salud [Internet]. La contención de la resistencia a los antimicrobianos. En: Perspectivas políticas de la OMS sobre los medicamentos. 2005; abril (10) [citado 12 abril 2012]. Disponible en: http://apps.who.int/medicinedocs/en/d/Js7922s/

  8. Byarugaba DK. A view on antimicrobial resistance in developing countries and responsible risk factors. Int J Antimicrob Agents. 2004 Aug;24(2):105-10.

  9. Murray PR, Washington JA. Microscopic and bacteriologic analysis of expectorated sputum. Mayo Clin Proc. 1975;50:339-44.

  10. Afessa B, Green B. Bacterial pneumonia in hospitalized patients with HIV infection: the pulmonary complications, ICU support, and prognostic factors of hospitalized patients with HIV (PIP) study. Chest. 2000;117:1017-22.

  11. Franzetti F, Grassini A, Piazza M, Degl'innocenti M, Bandera A. Nosocomial bacterial pneumonia in HIV-infected patients: risk factors for adverse outcome and implications for rational empiric antibiotic therapy. Infection. 2006 Feb;34(1):9-16.

  12. Park DR, Sherbin DL, Goodman MS, Pacífico A, Rubenfeld G, Polissar N, et al. The etiology of community-acquired pneumonia at an urban public hospital: influence of human immunodeficiency virus infection and initial severity. J Infect Dis. 2001;184:268-77.

  13. Salami AK, Olatunji PO, Oluboyo PO, Akanbi AA, Fawibe EA. Bacterial pneumonia in the AIDS patients. West Afr J Med. 2006 Jan-Mar;25(1):1-5.

  14. Sued O, Ben G, Pérez H. Cuidados intensivos en pacientes con infección por VIH. Patología de Urgencia. 2002;10:9-18.

  15. Campbell S, Marrie T, Anstey R, Ackroyd-Stolarz S, Dickinson G. Utility of blood cultures in the management of adults with community acquired pneumonia discharged from the emergency department. Emerg Med J. 2003;20:521-3.

  16. Fernández M, Zagolin M, Ruiz M, Martínez M, Díaz J. Neumonía adquirida en la comunidad que se hospitaliza: estudio etiológico. Rev Med Chile. 2003;13:498-504.

  17. Corbo J, Friedman B, Bijur P, Gallager EJ. Limitada utilidad de hemocultivos iniciales en neumonía adquirida en la comunidad. Emerg Med J. 2004;21:446-8.

  18. Luna CM. Blood cultures in community-acquired pneumonia: are we ready to quit? Chest. 2003;123(4):1142-50.

  19. Sadikot R, Blackwell T, Christman T, Prince A. Pathogenhost interactions in Pseudomonas aeruginosa pneumonia. Am J Resp Crit Care Med. 2005;171:1209-23.

  20. Pérez Monrás, Cabrera N, Batlle MC, Estévez R. Etiología bacteriana de las infecciones respiratorias agudas en pacientesVIH/sida. Rev Cubana Med Trop. 2002;54(2):147-51.

  21. Manfredi R, Nanetti A, Ferri M, Chiodo F. Pseudomonas spp. complications in patients with HIV disease: an eight-year clinical and microbiological survey. Eur J Epidemiol. 2000 Feb; 16(2):111-8.

  22. Livermore DM, Winstanley TG, Shannon KP. Interpretative reading: recognizing the unusual and inferring resistance mechanisms from resistance phenotypes. J Antimicrob Chemother. 2001;48(1):87-102.

  23. Xiong Z, Zhu D, Zhang Y, Wang F. Extended-spectrum beta-lactamase in Klebsiella pneumoniae and Escherichia coli isolates. Zhonghua Yi Xue Za Zhi. 2002 Nov 10;82(21):1476-9.

  24. Lee K, Lim CH, Cho JH, Lee WG, Uh Y, Kim HJ. High prevalence of ceftazidime-resistant Klebsiella pneumoniae and increase of imipenem-resistant Pseudomonas aeruginosa and Acinetobacter spp. in Korea: a KONSAR program in 2004. Yonsei Med J. 2006 Oct 31;47(5):634-45.

  25. Irfan S, Idrees F, Mehraj V, Habib F, Adil S. Emergence of Carbapenem resistant gramnegative and vancomycin resistant grampositive organisms in bacteremic isolates of febrile neutropenic patients: A descriptive study. BMC Infectious Dis. 2008;8:80.

  26. Paladino JA, Sunderlin JL, Singer ME, Adelman MH, Schentag JJ. Influence of extended-spectrum beta-lactams on gram-negative bacterial resistance. Am J Health Syst Pharm. 2008 Jun;15;65(12):1154-9.

  27. Rodríguez C, Martínez J. Vigilancia microbiológica en infecciones respiratorias bajas. Rev Cubana Hig Epidemiol. 2002 Sep-Dic;40(3).

  28. Zhanel G, DeCorby M, Nichol KA, Wierzbowski A, Baudry PJ. Antimicrobial susceptibility of 3931 organisms isolated from intensive care units in Canada: Canadian National Intensive Care Unit Study, 2005/2006. Diagn Microbiol Infect Dis. 2008 May;28:1134-9.

  29. Hernández W, Ramos A, Nodarse R, Padrón A, De Armas E. Resistencia bacteriana en las bacterias productoras de betalactamasas extendidas (BLEE). Revista Cubana de Medicina Intensiva y Emergencias 2006 [citado 2008 Nov 12; 5(1) [aprox 2p.] Disponible en: http://bvs.sld.cu/revistas/mie/vol5_1_06/mie03106.htm

  30. Zhanel G, DeCorby M, Laing N, Weshnoweski B, Vashisht R. Antimicrobial-resistant pathogens in intensive care units in Canada: results of the Canadian National Intensive Care Unit (CAN-ICU) study, 2005-2006. Antimicrob Agents Chemother. 2008 Apr;52(4):1430-7.

  31. Gad GF, El-Domany RA, Ashour HM. Antimicrobial susceptibility profile of Pseudomonas aeruginosa isolates in Egypt. J Urol. 2008 Jul;180(1):176-81.

  32. Vila J, Marco F. Lectura interpretada del antibiograma de bacilos gramnegativos no fermentadores. Enferm Infecc Microbiol Clin. 2002;20(6):304-12.

  33. Poole K. Multidrug efflux pumps and antimicrobial resistance in Pseudomonas aeruginosa and related organisms. J Mol Microbiol Biotechnol. 2001;3:255-64.

  34. Srifuengfung S, Tribuddharat C, Yungyuen T, Wensentia T. Respiratory tract infection caused by bacteria (non-Mycobacterium) and their antibiogram in HIV-positive patients. Southeast Asian J Trop Med Public Health. 2005 May;36(3):709-12.

  35. Salazar D, González A, Palma S. Susceptibilidad antimicrobiana y serotipaje de Pseudomonas aeruginosa aisladas de pacientesVIH/sida. Rev Cubana Med Trop. 2002 [citado 2007 Dic 12]; 54(2): [aprox 2p.]. Disponible en: http://www.bvs.sld.cu/revistas/mtr/vol54_2_02/mtr10202.htm




2020     |     www.medigraphic.com